My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Iron and aluminum homeostasis in neural disorders.

    Joshi JG, Dhar M, Clauberg M, Chauthaiwale V.

    Environ Health Perspect. 1994 Sep;102 Suppl 3:207-13. Review.PMID: 7843099 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Regulation of serine protease activity by aluminum: implications for Alzheimer disease.

    Clauberg M, Joshi JG.

    Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1009-12.PMID: 7679214 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.

    Piñero DJ, Hu J, Connor JR.

    Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):761-76.PMID: 10875438 [PubMed - indexed for MEDLINE]Related articles

    4.

    A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains.

    Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P.

    J Neurochem. 1995 Aug;65(2):717-24.PMID: 7616228 [PubMed - indexed for MEDLINE]Related articles

    5.

    Neurochemical hypothesis: participation by aluminum in producing critical mass of colocalized errors in brain leads to neurological disease.

    Joshi JG.

    Comp Biochem Physiol C. 1991;100(1-2):103-5. Review.PMID: 1677837 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.

    Thompson K, Menzies S, Muckenthaler M, Torti FM, Wood T, Torti SV, Hentze MW, Beard J, Connor J.

    J Neurosci Res. 2003 Jan 1;71(1):46-63.PMID: 12478613 [PubMed - indexed for MEDLINE]Related articles

    7.

    Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.

    House E, Collingwood J, Khan A, Korchazkina O, Berthon G, Exley C.

    J Alzheimers Dis. 2004 Jun;6(3):291-301.PMID: 15201484 [PubMed - indexed for MEDLINE]Related articles

    8.

    Ferritin: the role of aluminum in ferritin function.

    Fleming JT, Joshi JG.

    Neurobiol Aging. 1991 Sep-Oct;12(5):413-8.PMID: 1770974 [PubMed - indexed for MEDLINE]Related articles

    9.

    The redox chemistry of the Alzheimer's disease amyloid beta peptide.

    Smith DG, Cappai R, Barnham KJ.

    Biochim Biophys Acta. 2007 Aug;1768(8):1976-90. Epub 2007 Feb 9. Review.PMID: 17433250 [PubMed - indexed for MEDLINE]Related articles

    10.

    Advanced glycation end products contribute to amyloidosis in Alzheimer disease.

    Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A.

    Proc Natl Acad Sci U S A. 1994 May 24;91(11):4766-70.PMID: 8197133 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Aluminum-induced structural alterations of the precursor of the non-A beta component of Alzheimer's disease amyloid.

    Paik SR, Lee JH, Kim DH, Chang CS, Kim J.

    Arch Biochem Biophys. 1997 Aug 15;344(2):325-34.PMID: 9264546 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases.

    Kawahara M.

    J Alzheimers Dis. 2005 Nov;8(2):171-82; discussion 209-15. Review.PMID: 16308486 [PubMed - indexed for MEDLINE]Related articles

    13.

    Production of amyloid beta protein from normal amyloid beta-protein precursor (beta APP) and the mutated beta APPS linked to familial Alzheimer's disease.

    Golde TE, Cai XD, Shoji M, Younkin SG.

    Ann N Y Acad Sci. 1993 Sep 24;695:103-8. Review.PMID: 8239266 [PubMed - indexed for MEDLINE]Related articles

    14.

    A novel ferritin heavy chain messenger ribonucleic acid in the human brain.

    Joshi JG, Fleming JT, Dhar M, Chauthaiwale V.

    J Neurol Sci. 1995 Dec;134 Suppl:52-6.PMID: 8847545 [PubMed - indexed for MEDLINE]Related articles

    15.

    Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease.

    Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ.

    J Neurosci Res. 1992 Feb;31(2):327-35.PMID: 1573683 [PubMed - indexed for MEDLINE]Related articles

    16.

    Aluminum, a neurotoxin which affects diverse metabolic reactions.

    Joshi JG.

    Biofactors. 1990 Jul;2(3):163-9. Review.PMID: 2198876 [PubMed - indexed for MEDLINE]Related articles

    17.

    In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.

    Kubo T, Nishimura S, Kumagae Y, Kaneko I.

    J Neurosci Res. 2002 Nov 1;70(3):474-83.PMID: 12391608 [PubMed - indexed for MEDLINE]Related articles

    18.

    A new model for the pathophysiology of Alzheimer's disease. Aluminium toxicity is exacerbated by hydrogen peroxide and attenuated by an amyloid protein fragment and melatonin.

    van Rensburg SJ, Daniels WM, Potocnik FC, van Zyl JM, Taljaard JJ, Emsley RA.

    S Afr Med J. 1997 Sep;87(9):1111-5.PMID: 9358827 [PubMed - indexed for MEDLINE]Related articles

    19.

    Aluminum and Alzheimer's disease.

    McLachlan DR.

    Neurobiol Aging. 1986 Nov-Dec;7(6):525-32. Review.PMID: 3550508 [PubMed - indexed for MEDLINE]Related articles

    20.

    Altered calcium signaling and neuronal injury: stroke and Alzheimer's disease as examples.

    Mattson MP, Rydel RE, Lieberburg I, Smith-Swintosky VL.

    Ann N Y Acad Sci. 1993 May 28;679:1-21. Review.PMID: 8512177 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity